75 related articles for article (PubMed ID: 25369246)
1. Early sodium dodecyl sulfate induced collapse of α-synuclein correlates with its amyloid formation.
Basak S; Prasad GV; Varkey J; Chattopadhyay K
ACS Chem Neurosci; 2015 Feb; 6(2):239-46. PubMed ID: 25369246
[TBL] [Abstract][Full Text] [Related]
2. Membrane remodeling by α-synuclein and effects on amyloid formation.
Jiang Z; de Messieres M; Lee JC
J Am Chem Soc; 2013 Oct; 135(43):15970-3. PubMed ID: 24099487
[TBL] [Abstract][Full Text] [Related]
3. Early aggregation steps in alpha-synuclein as measured by FCS and FRET: evidence for a contagious conformational change.
Nath S; Meuvis J; Hendrix J; Carl SA; Engelborghs Y
Biophys J; 2010 Apr; 98(7):1302-11. PubMed ID: 20371330
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Structural and Thermodynamic Analysis of Prefibrillar WT α-Synuclein and Its G51D, E46K, and A53T Mutants by a Combination of Small-Angle X-ray Scattering and Variational Bayesian Weighting.
Moretti P; Mariani P; Ortore MG; Plotegher N; Bubacco L; Beltramini M; Spinozzi F
J Chem Inf Model; 2020 Oct; 60(10):5265-5281. PubMed ID: 32866007
[TBL] [Abstract][Full Text] [Related]
5. Visualizing a one-way protein encounter complex by ultrafast single-molecule mixing.
Gambin Y; VanDelinder V; Ferreon AC; Lemke EA; Groisman A; Deniz AA
Nat Methods; 2011 Mar; 8(3):239-41. PubMed ID: 21297620
[TBL] [Abstract][Full Text] [Related]
6. A relationship between the transient structure in the monomeric state and the aggregation propensities of α-synuclein and β-synuclein.
Allison JR; Rivers RC; Christodoulou JC; Vendruscolo M; Dobson CM
Biochemistry; 2014 Nov; 53(46):7170-83. PubMed ID: 25389903
[TBL] [Abstract][Full Text] [Related]
7. Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation.
Lázaro DF; Rodrigues EF; Langohr R; Shahpasandzadeh H; Ribeiro T; Guerreiro P; Gerhardt E; Kröhnert K; Klucken J; Pereira MD; Popova B; Kruse N; Mollenhauer B; Rizzoli SO; Braus GH; Danzer KM; Outeiro TF
PLoS Genet; 2014 Nov; 10(11):e1004741. PubMed ID: 25393002
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of the early events of α-synuclein aggregation: a fluorescence correlation spectroscopy and laser scanning microscopy study in the presence of surface-coated Fe3O4 nanoparticles.
Joshi N; Basak S; Kundu S; De G; Mukhopadhyay A; Chattopadhyay K
Langmuir; 2015 Feb; 31(4):1469-78. PubMed ID: 25561279
[TBL] [Abstract][Full Text] [Related]
9. Acceleration of α-synuclein aggregation by exosomes.
Grey M; Dunning CJ; Gaspar R; Grey C; Brundin P; Sparr E; Linse S
J Biol Chem; 2015 Jan; 290(5):2969-82. PubMed ID: 25425650
[TBL] [Abstract][Full Text] [Related]
10. Early and persistent expression of phosphorylated α-synuclein in the enteric nervous system of A53T mutant human α-synuclein transgenic mice.
Bencsik A; Muselli L; Leboidre M; Lakhdar L; Baron T
J Neuropathol Exp Neurol; 2014 Dec; 73(12):1144-51. PubMed ID: 25383638
[TBL] [Abstract][Full Text] [Related]
11. In vivo markers of Parkinson's disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody.
Maetzler W; Pilotto A; Apel A; Deuschle C; Kuebart G; Heinzel S; Liepelt-Scarfone I; Schulte C; Reusch D; Schleicher E; Rothfuss O; Schneider A; Dodel R; Gasser T; Berg D
Acta Neuropathol; 2014 Dec; 128(6):893-5. PubMed ID: 25376537
[No Abstract] [Full Text] [Related]
12. Purification of α-synuclein from human brain reveals an instability of endogenous multimers as the protein approaches purity.
Luth ES; Bartels T; Dettmer U; Kim NC; Selkoe DJ
Biochemistry; 2015 Jan; 54(2):279-92. PubMed ID: 25490121
[TBL] [Abstract][Full Text] [Related]
13. Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's disease.
Compta Y; Valente T; Saura J; Segura B; Iranzo Á; Serradell M; Junqué C; Tolosa E; Valldeoriola F; Muñoz E; Santamaria J; Cámara A; Fernández M; Fortea J; Buongiorno M; Molinuevo JL; Bargalló N; Martí MJ
J Neurol; 2015 Feb; 262(2):294-306. PubMed ID: 25380583
[TBL] [Abstract][Full Text] [Related]
14. Head injury, α-synuclein genetic variability and Parkinson's disease.
Lee PC; Bordelon Y; Bronstein J; Sinsheimer JS; Farrer M; Ritz B
Eur J Neurol; 2015 May; 22(5):874-8. PubMed ID: 25370538
[TBL] [Abstract][Full Text] [Related]
15. CSF biomarkers and clinical progression of Parkinson disease.
Hall S; Surova Y; Öhrfelt A; Zetterberg H; Lindqvist D; Hansson O
Neurology; 2015 Jan; 84(1):57-63. PubMed ID: 25411441
[TBL] [Abstract][Full Text] [Related]
16. Isolation and functional analysis of yeast ubiquitin ligase Rsp5 variants that alleviate the toxicity of human α-synuclein.
Wijayanti I; Watanabe D; Oshiro S; Takagi H
J Biochem; 2015 Apr; 157(4):251-60. PubMed ID: 25398992
[TBL] [Abstract][Full Text] [Related]
17. ATP13A2/PARK9 regulates secretion of exosomes and α-synuclein.
Tsunemi T; Hamada K; Krainc D
J Neurosci; 2014 Nov; 34(46):15281-7. PubMed ID: 25392495
[TBL] [Abstract][Full Text] [Related]
18. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
[TBL] [Abstract][Full Text] [Related]
19. Structure based aggregation studies reveal the presence of helix-rich intermediate during α-Synuclein aggregation.
Ghosh D; Singh PK; Sahay S; Jha NN; Jacob RS; Sen S; Kumar A; Riek R; Maji SK
Sci Rep; 2015 Mar; 5():9228. PubMed ID: 25784353
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic mechanisms of neurodegeneration in Parkinson disease.
Mullin S; Schapira AH
Neurol Clin; 2015 Feb; 33(1):1-17. PubMed ID: 25432720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
